This item is part of Stockwatch's value added news feed and is only available to Stockwatch subscribers.Here is a sample of this item:Dendreon Announces Webcast Presentations at Upcoming Investor Conferences 2009-11-25 07:30 ET - News Release SEATTLE, Nov. 25 /PRNewswire-FirstCall/ -- Dendreon Corporation today announced that management will present at the following two investor conferences next month.
NASDAQ OMX 23rd Investor Program, London
Tuesday, December 1, 2009
4:30 a.m. ET
2009 Deutsche Bank Biotech Boston Confab
Tuesday, December 15, 2009
10:00 a.m. ET
The presentations will be audio webcast live and available for replay from Dendreon's website, www.dendreon.com. Dendreon Corporation is a biotechnology company whose mission is to target cancer and transform lives through the discovery, development and commercialization of novel therapeutics. The Company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy product candidates designed to stimulate an immune response. Dendreon is also developing an orally-available small molecule that targets TRPM8 that could be applicable to multiple types of cancer as well as benign prostatic hyperplasia. The Company has its headquarters in Seattle, Washington and is traded on the Nasdaq Global Market under the symbol DNDN. For more information about the Company and its programs, visit www.dendreon.com. Dendreon Corporation The remainder is available to Stockwatch subscribers.
If you would like to give the Stockwatch system a try,
click here for a free 30 day trial subscription. | 
Top
Print this Page